Cardiovascular Findings on Chest Computed Tomography Associated with COVID-19 Adverse Clinical Outcomes
Overview
Authors
Affiliations
Study Objective: Chest computed tomography (chest CT) is routinely obtained to assess disease severity in COVID-19. While pulmonary findings are well-described in COVID-19, the implications of cardiovascular findings are less well understood. We evaluated the impact of cardiovascular findings on chest CT on the adverse composite outcome (ACO) of hospitalized COVID-19 patients.
Setting/participants: 245 COVID-19 patients who underwent chest CT at Rush University Health System were included.
Design: Cardiovascular findings, including coronary artery calcification (CAC), aortic calcification, signs of right ventricular strain [right ventricular to left ventricular diameter ratio, pulmonary artery to aorta diameter ratio, interventricular septal position, and inferior vena cava (IVC) reflux], were measured by trained physicians.
Interventions/main Outcome Measures: These findings, along with pulmonary findings, were analyzed using univariable logistic analysis to determine the risk of ACO defined as intensive care admission, need for non-invasive positive pressure ventilation, intubation, in-hospital and 60-day mortality. Secondary endpoints included individual components of the ACO.
Results: Aortic calcification was independently associated with an increased risk of the ACO (odds ratio 1.86, 95% confidence interval (1.11-3.17) < 0.05). Aortic calcification, CAC, abnormal septal position, or IVC reflux of contrast were all significantly associated with 60-day mortality and major adverse cardiovascular events. IVC reflux was associated with in-hospital mortality ( = 0.005).
Conclusion: Incidental cardiovascular findings on chest CT are clinically important imaging markers in COVID-19. It is important to ascertain and routinely report cardiovascular findings on CT imaging of COVID-19 patients as they have potential to identify high risk patients.
Correlation between coronary artery calcification and COVID-19.
Abrotan S, Jalali S, Hedayati-Godarzi M, Jafaripour I, Saravi M, Ziaie N Caspian J Intern Med. 2024; 15(3):466-471.
PMID: 39011441 PMC: 11246690. DOI: 10.22088/cjim.15.3.466.
Hedayati Goudarzi M, Abrotan S, Ziaie N, Amin K, Saravi M, Jalali S Ann Med Surg (Lond). 2024; 86(6):3227-3232.
PMID: 38846865 PMC: 11152861. DOI: 10.1097/MS9.0000000000001661.
Kotlo S, Thorgerson A, Kulinski J Am Heart J Plus. 2023; 28:100288.
PMID: 36925617 PMC: 9993728. DOI: 10.1016/j.ahjo.2023.100288.
Advanced cardiac imaging in the spectrum of COVID-19 related cardiovascular involvement.
Palmisano A, Gambardella M, DAngelo T, Vignale D, Ascione R, Gatti M Clin Imaging. 2022; 90:78-89.
PMID: 35930942 PMC: 9335398. DOI: 10.1016/j.clinimag.2022.07.009.
Szarpak L, Mierzejewska M, Jurek J, Kochanowska A, Gasecka A, Truszewski Z Biology (Basel). 2022; 11(2).
PMID: 35205088 PMC: 8868600. DOI: 10.3390/biology11020221.